Advanced Eye Relief/ Redness Maximum Relief (Bausch & Lomb Incorporated)


Welcome to the PulseAid listing for the Advanced Eye Relief/ Redness Maximum Relief drug offered from Bausch & Lomb Incorporated. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Bausch & Lomb Incorporated
NON-PROPRIETARY NAME: Naphazoline Hydrochloride and Hypromellose
SUBSTANCE NAME: HYPROMELLOSES; NAPHAZOLINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2010-09-02
END MARKETING DATE: 0000-00-00


Advanced Eye Relief/ Redness Maximum Relief HUMAN OTC DRUG Details:

Item DescriptionAdvanced Eye Relief/ Redness Maximum Relief from Bausch & Lomb Incorporated
LABELER NAME: Bausch & Lomb Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 5; .3(mg/mL; mg/mL)
START MARKETING DATE: 2010-09-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24208-450_332e281a-555d-4d1e-8f6b-47a8219a23af
PRODUCT NDC: 24208-450
APPLICATION NUMBER: part349

Other HYPROMELLOSES; NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedAdvanced Eye Relief/ Redness Maximum Relief